Non-Hodgkin Lymphoma – Pipeline Review, H2 2020

Global Markets Direct’s, ‘Non-Hodgkin Lymphoma – Pipeline Review, H2 2020’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Non-Hodgkin Lymphoma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

– The report provides a snapshot of the global therapeutic landscape of Non-Hodgkin Lymphoma

– The report reviews pipeline therapeutics for Non-Hodgkin Lymphoma by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Non-Hodgkin Lymphoma therapeutics and enlists all their major and minor projects

– The report assesses Non-Hodgkin Lymphoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Non-Hodgkin Lymphoma

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Non-Hodgkin Lymphoma

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Non-Hodgkin Lymphoma pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

3SBio Inc

4SC AG

A. Menarini Industrie Farmaceutiche Riunite Srl

AB Science SA

AbbVie Inc

ABIONYX Pharma SA

Abologix Sarl

ACEA Therapeutics Inc

Acerta Pharma BV

Acrotech Biopharma LLC

Actinium Pharmaceuticals Inc

Adagene Suzhou Ltd

ADC Therapeutics SA

Adicet Bio Inc

Adienne Pharma & Biotech

Adlai Nortye Biopharma Co Ltd

Advenchen Laboratories LLC

Affimed GmbH

Affitech A/S

AGC Biologics SpA

AgenTus Therapeutics Inc

Agenus Inc

Agios Pharmaceuticals Inc

AI Therapeutics Inc

Akeso Inc

Aleta Biotherapeutics Inc

Alexion Pharmaceuticals Inc

Alfasigma SpA

Allarity Therapeutics A/S

Alopexx Oncology LLC

Alphamab Oncology

ALX Oncology Inc

Amgen Inc

Anew Oncology Inc

Angimmune LLC

Angiocrine Bioscience Inc

Anhui Anke Biotechnology (Group) Co Ltd

Antengene Corp

AP Biosciences Inc

Apollomics Inc

Apotex Inc

Applied Therapeutics Inc

Aprea Therapeutics Inc

Archigen Biotech Ltd

Argenx SE

Arrien Pharmaceuticals LLC

Ascentage Pharma Group International

Astellas Pharma Inc

Astex Pharmaceuticals Inc

AstraZeneca Plc

AUM Biosciences Pte Ltd

Aurigene Discovery Technologies Ltd

Autolus Therapeutics Plc

Avalon GloboCare Corp

Avipep Pty Ltd

AVM Biotechnology LLC

AzarGen Biotechnologies (Pty) Ltd

Bantam Pharmaceutical LLC

Bayer AG

BeiGene Ltd

Beijing GD Initiative Cell Therapy Technology Co Ltd

Beijing Immunochina Pharmaceuticals Co Ltd

Beijing Luzhu Biotechnology Co Ltd

Beijing Mabworks Biotech Co Ltd

Beijing Shenzhou Cell Biotechnology Group Co Ltd

Bellicum Pharmaceuticals Inc

BendaRx Corp

Betta Pharmaceuticals Co Ltd

Bio-Path Holdings Inc

Bio-Thera Solutions Ltd

BioCurate Pty Ltd

BioEclipse Therapeutics Inc

Biogen Inc

BioIntegrator Ltd

BioInvent International AB

BioLineRx Ltd

Bioniz Therapeutics Inc

BioNTech SE

BioPact Ventures LLC

BioXpress Therapeutics SA

BiVictriX Therapeutics Ltd

bluebird bio Inc

Boehringer Ingelheim International GmbH

Boryung Pharmaceutical Co Ltd

Boryung ViGenCell Inc

Brickell Biotech Inc

Bristol-Myers Squibb Co

C4 Therapeutics Inc

Cardiff Oncology Inc

Caribou Biosciences Inc

Carrick Therapeutics Ltd

CARsgen Therapeutics Ltd

Cartherics Pty Ltd

CASI Pharmaceuticals Inc

Catalent Inc

Catapult Therapeutics BV

Celdara Medical LLC

Cell Source Inc

Cell>Point LLC

CellCentric Ltd

Celldex Therapeutics Inc

Cellectar Biosciences Inc

Cellectis SA

Celleron Therapeutics Ltd

Cellestia Biotech AG

Celltrion Inc

Cellular Biomedicine Group Inc

Cellular Biomedicine Group Ltd

Celularity Inc

Centrose LLC

CerRx Inc

CGeneTech (Suzhou China) Co Ltd

Checkmate Pharmaceuticals Inc

Checkpoint Therapeutics Inc

Chengdu Brilliant Pharmaceutical Co Ltd

China Immunotech Co Ltd

CHO Pharma Inc

Chordia Therapeutics Inc

Chugai Pharmaceutical Co Ltd

Cielo Therapeutics Inc

Clayton Biotechnologies Inc

Clevexel Pharma SA

Codiak BioSciences Inc

Cogent Biosciences Inc

CoImmune Inc

Constellation Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

CRISPR Therapeutics AG

CrystalGenomics Inc

CSL Ltd

CSPC Pharmaceutical Group Ltd

CStone Pharmaceuticals Co Ltd

Cullinan Oncology LLC

Curis Inc

Curocell Inc

Cyclacel Pharmaceuticals Inc

Cyteir Therapeutics Inc

CytomX Therapeutics Inc

Daiichi Sankyo Co Ltd

Daysai Biopharmaceuticals Inc

Debiopharm International SA

Decoy Biosystems Inc

Denovo Biopharma LLC

Dizal (Jiangsu) Pharmaceutical Co Ltd

Dr. Reddy's Laboratories Ltd

Dragonfly Therapeutics Inc

eFFECTOR Therapeutics Inc

Eisai Co Ltd

Eli Lilly and Co

Enterome Bioscience SA

Epidestiny Inc

Epizyme Inc

ERYTECH Pharma SA

Esanex Inc

Eternity Bioscience Inc

Eureka Therapeutics Inc

Eutilex Co Ltd

Evive Biotech

Evotec SE

Exinda Therapeutics LLC

F. Hoffmann-La Roche Ltd

Fate Therapeutics Inc

Fujifilm Holdings Corp

Galderma SA

Gamida Cell Ltd

GC Pharma

Geneius Biotechnology Inc

Genentech USA Inc

Geneos Therapeutics Inc

GeneScience Pharmaceuticals Co Ltd

Genexine Inc

GenFleet Therapeutics (Shanghai) Inc

Genmab AS

Genor BioPharma Co Ltd

Genosco Inc

Gibson Oncology LLC

Gilead Sciences Inc

GlaxoSmithKline Plc

GPCR Therapeutics Inc

Gracell Biotechnology Ltd

Grupo Ferrer Internacional SA

GT Biopharma Inc

Guangdong Zhongsheng Pharmaceutical Co Ltd

Guangzhou Bio-gene Technology Co Ltd

H3 Biomedicine Inc

Hangzhou Hezheng Pharmaceutical Co Ltd

Hangzhou Minsheng Pharmaceutical Group Co Ltd

Hangzhou Zenshine Pharmaceuticals Co Ltd

Harbin Gloria Pharmaceuticals Co Ltd

Harpoon Therapeutics Inc

Hebei Senlang Biotechnology Inc Ltd

HEC Pharm Co Ltd

Heidelberg Pharma AG

Helocyte Biosciences Inc

Helsinn Group

Hengenix Biotech Inc

Hibercell Inc

HRAIN Biotechnology Co Ltd

Hualan Biological Engineering Inc

Humanigen Inc

Hunan Siweikang Therapeutics Ltd

Hutchison MediPharma Ltd

I-Mab

iBio Inc

iCell Gene Therapeutics LLC

IGM Biosciences Inc

Iksuda Therapeutics Ltd

ImCheck Therapeutics SAS

Immune Cell Inc

ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd

ImmuneTarget Inc

ImmunityBio Inc

ImmunoGen Inc

Immunomet Therapeutics Inc

Immunotech Biopharm Ltd

Impetis Biosciences Ltd

IMV Inc

Inatherys

Incuron LLC

Incyte Corp

Inflection Biosciences Ltd

Inhibrx Inc

Innate Pharma SA

InnoCare Pharma Ltd

Innovative Cellular Therapeutics Co Ltd

Innovent Biologics Inc

IO Biotech ApS

Ionis Pharmaceuticals Inc

Japan Tobacco Inc

Jazz Pharmaceuticals Plc

Jiangsu Carephar Pharmaceutical Co Ltd

Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Maidu Drug Research and Development Co Ltd

JN Biosciences LLC

Johnson & Johnson

Jubilant Therapeutics Inc

Juno Therapeutics Inc

Juventas Cell Therapy Ltd

JW Therapeutics Shanghai Co Ltd

Kainos Medicine Inc

Kangpu Biopharmaceuticals Ltd

Kartos Therapeutics Inc

Karus Therapeutics Ltd

Karyopharm Therapeutics Inc

Kecellitics Biotech Co Ltd

Kiniksa Pharmaceuticals Ltd

Kiromic BioPharma Inc

Klyss Biotech Inc

Komipharm International Co Ltd

Kronos Bio Inc

Kuur Therapeutics Ltd

Kymera Therapeutics LLC

Kyowa Kirin Co Ltd

Lanzhou Institute of Biological Products Co Ltd

Legend Biotech Corp

LegoChem Biosciences Inc

Lepu Medical Technology (Beijing) Co Ltd

Les Laboratoires Servier SAS

LFB SA

Light Chain Bioscience

LintonPharm Co Ltd

Loxo Oncology Inc

Luminary Therapeutics Inc

Lupin Ltd

Mabion SA

Mablink Bioscience

Machavert Pharmaceuticals LLC

MacroGenics Inc

Magenta Therapeutics Inc

ManysmarT Therapeutics Inc

Marino Biotechnology Co Ltd

Marker Therapeutics Inc

Meabco AS

MedC Biopharma Ltd

MediGene AG

MediSix Therapeutics Pte Ltd

Meditope Biosciences Inc

Medivir AB

MedPacto Inc

MEI Pharma Inc

MENTRIK Biotech LLC

Merck & Co Inc

Merck KGaA

Millennium Pharmaceuticals Inc

Miltenyi Biotec BV & Co KG

Miragen Therapeutics Inc

Mirati Therapeutics Inc

Moderna Inc

Molecular Templates Inc

Moleculin Biotech Inc

MorphoSys AG

Mustang Bio Inc

Myeloid Therapeutics Inc

Nanjing Bioheng Biotech Co Ltd

Nanjing Iaso Biotherapeutics Co Ltd

Nanjing KAEDI Biotech Inc

Nanjing Sanhome Pharmaceutical Co Ltd

Nanolek LLC

Nanoligent SL

NantKwest Inc

Navrogen Inc

Nektar Therapeutics

Neoleukin Therapeutics Inc

Neonc Technologies Inc

Neumedicines Inc

Newave Pharmaceutical Inc

NewBio Therapeutics Inc

Nichi-Iko Pharmaceutical Co Ltd

Nordic Nanovector ASA

Northlake International LLC

NovalGen Ltd

Novartis AG

Onco Therapies Inc

Oncoceutics Inc

Onconova Therapeutics Inc

Oncopeptides AB

OncoTartis Inc

Oncovir Inc

Oncternal Therapeutics

OnKure Inc

Ono Pharmaceutical Co Ltd

Orano Med LLC

Orsenix Holdings BV

Otsuka Holdings Co Ltd

Oxford BioTherapeutics Ltd

Pacylex Pharmaceuticals Inc

PeproMene Bio Inc

PersonGen Biomedicine Suzhou Co Ltd

PersonGen BioTherapeutics Suzhou Co Ltd

Pfizer Inc

Pharmapraxis

Philogen SpA

PIQUR Therapeutics AG

Plexxikon Inc

Precision Biosciences Inc

Prelude Therapeutics Inc

Prescient Therapeutics Ltd

Protheragen Inc

Quimatryx SL

Rafael Pharmaceuticals Inc

RAPT Therapeutics Inc

Regeneron Pharmaceuticals Inc

Replimune Ltd

Rescue Therapeutics Inc

Respiratorius AB

Rhizen Pharmaceuticals SA

Ribon Therapeutics Inc

Ryvu Therapeutics SA

Samumed LLC

Sanofi

Sareum Holdings Plc

SciTech Development LLC

Scopus BioPharma Inc

Seagen Inc

Secura Bio Inc

selectION Inc

Senhwa Biosciences Inc

SHAL Technologies Inc

Shandong New Time Pharmaceutical Co Ltd

Shandong Qidu Pharmaceutical Co Ltd

Shanghai Bioray Laboratory Inc

Shanghai Cell Therapy Group Co

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Shanghai GeneChem Co Ltd

Shanghai Haihe Biopharma Co Ltd

Shanghai Institute of Biological Products Co Ltd

Shanghai Junshi Bioscience Co Ltd

Shanghai Longyao Biotechnology Inc Ltd

Shanghai Miracogen Inc

Shanghai Pharmaceutical Group Co Ltd

Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

Shanghai YaKe Biotechnology Inc

Shanghai Yingli Pharmaceutical Co Ltd

Shattuck Labs Inc

Shengke Pharmaceuticals (Jiangsu) Ltd

Shenzhen BinDeBio Ltd

Shenzhen Chipscreen Biosciences Co Ltd

Shenzhen Salubris Pharmaceuticals Co Ltd

Sian Wuhan Medical Technology Co Ltd

Sichuan Haisco Pharmaceutical Co Ltd

Sichuan Kelun Pharmaceutical Co Ltd

SideROS

SignalRx Pharmaceuticals Inc

Sino Biopharmaceutical Ltd

SinoMab Bioscience Ltd

Solasia Pharma KK

Soligenix Inc

Sonoval LLC

Sorrento Therapeutics Inc

SpecificiT Pharma Inc

Spectrum Pharmaceuticals Inc

SumiQ Therapeutics BV

Sumitomo Dainippon Pharma Oncology, Inc

Supratek Pharma Inc

Surface Oncology Inc

Sutro Biopharma Inc

Suzhou Sinovent Pharmaceuticals Co Ltd

Syndax Pharmaceuticals Inc

Systimmune Inc

Tacitus Therapeutics Inc

Taiwan Liposome Co Ltd

Takara Bio Inc

Takeda Pharmaceutical Co Ltd

Tayu Huaxia Biotech Medical Group Co Ltd

TC BioPharm Ltd

TCR Cure Biopharma Technology Co Ltd

TCR2 Therapeutics Inc

TeneoBio Inc

Tessa Therapeutics Ltd

TG Therapeutics Inc

Timmune Biotech Inc

TOT Biopharm Co Ltd

Transgene Biotek Ltd

Transgene SA

Trillium Therapeutics Inc

Triphase Accelerator Corp

Triumvira Immunologics Inc

Truvitech LLC

Turning Point Therapeutics Inc

Tyme Technologies Inc

United BioPharma Inc

UWELL Biopharma Inc

VelosBio Inc

Vidac Pharma Ltd

Vincera Pharma Inc

Viracta Therapeutics Inc

Vivolux AB

VM Discovery Inc

Vyriad Inc

Wellington Zhaotai Therapies Ltd

Wugen Inc

Wuhan Bio-Raid Biotechnology Co Ltd

X4 Pharmaceuticals Inc

Xcovery Holding Co LLC

XEME BioPharma Inc

Xencor Inc

Xenetic Biosciences Inc

Xynomic Pharmaceuticals Holdings Inc

Xyphos Biosciences Inc

Zentalis Pharmaceuticals Inc

Zhejiang DTRM Biopharma LLC

Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Teruisi Pharmaceutical Co Ltd

Zhengda Tianqing Pharmaceutical Group Co Ltd

Zhuobo Yong Ji (Shanghai) Biological Pharmaceutical Co Ltd

ZIOPHARM Oncology Inc

Zumutor Biologics Inc

Zymeworks Inc

Table of Contents

Table of Contents

Introduction

Non-Hodgkin Lymphoma- Overview

Non-Hodgkin Lymphoma- Therapeutics Development

Non-Hodgkin Lymphoma- Therapeutics Assessment

Non-Hodgkin Lymphoma- Companies Involved in Therapeutics Development

Non-Hodgkin Lymphoma- Drug Profiles

Non-Hodgkin Lymphoma- Dormant Projects

Non-Hodgkin Lymphoma- Discontinued Products

Non-Hodgkin Lymphoma- Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Non-Hodgkin Lymphoma, H2 2020

Number of Products under Development by Companies, H2 2020

Number of Products under Development by Universities/Institutes, H2 2020

Products under Development by Companies, H2 2020

Products under Development by Universities/Institutes, H2 2020

Number of Products by Stage and Target, H2 2020

Number of Products by Stage and Mechanism of Action, H2 2020

Number of Products by Stage and Route of Administration, H2 2020

Number of Products by Stage and Molecule Type, H2 2020

Non-Hodgkin Lymphoma – Pipeline by 3SBio Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by 4SC AG, H2 2020

Non-Hodgkin Lymphoma – Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AB Science SA, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AbbVie Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by ABIONYX Pharma SA, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Abologix Sarl, H2 2020

Non-Hodgkin Lymphoma – Pipeline by ACEA Therapeutics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Acerta Pharma BV, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Acrotech Biopharma LLC, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Actinium Pharmaceuticals Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Adagene Suzhou Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by ADC Therapeutics SA, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Adicet Bio Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Adienne Pharma & Biotech, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Adlai Nortye Biopharma Co Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Advenchen Laboratories LLC, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Affimed GmbH, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Affitech A/S, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AGC Biologics SpA, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AgenTus Therapeutics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Agenus Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Agios Pharmaceuticals Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AI Therapeutics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Akeso Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Aleta Biotherapeutics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Alexion Pharmaceuticals Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Alfasigma SpA, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Allarity Therapeutics A/S, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Alopexx Oncology LLC, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Alphamab Oncology, H2 2020

Non-Hodgkin Lymphoma – Pipeline by ALX Oncology Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Amgen Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Anew Oncology Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Angimmune LLC, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Angiocrine Bioscience Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Antengene Corp, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AP Biosciences Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Apollomics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Apotex Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Applied Therapeutics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Aprea Therapeutics Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Archigen Biotech Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Argenx SE, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Arrien Pharmaceuticals LLC, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Ascentage Pharma Group International, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Astellas Pharma Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Astex Pharmaceuticals Inc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AstraZeneca Plc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AUM Biosciences Pte Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Aurigene Discovery Technologies Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Autolus Therapeutics Plc, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Avalon GloboCare Corp, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Avipep Pty Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by AVM Biotechnology LLC, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Lupin Ltd, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Mabion SA, H2 2020

Non-Hodgkin Lymphoma – Pipeline by Mablink Bioscience, H2 2020

List of Figures

List of Figures

Number of Products under Development for Non-Hodgkin Lymphoma, H2 2020

Number of Products under Development by Companies, H2 2020

Number of Products under Development by Universities/Institutes, H2 2020

Number of Products by Top 10 Targets, H2 2020

Number of Products by Stage and Top 10 Targets, H2 2020

Number of Products by Top 10 Mechanism of Actions, H2 2020

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020

Number of Products by Top 10 Routes of Administration, H2 2020

Number of Products by Stage and Top 10 Routes of Administration, H2 2020

Number of Products by Top 10 Molecule Types, H2 2020

Number of Products by Stage and Top 10 Molecule Types, H2 2020

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports